ClinicalTrials.Veeva

Menu

Physiological and Appetitive Effects of CBD Supplementation

L

Loughborough University

Status

Enrolling

Conditions

Appetitive Behavior
Adverse Effect
Metabolic Health

Treatments

Dietary Supplement: Placebo supplementation
Dietary Supplement: Cannabidiol (CBD) supplementation

Study type

Interventional

Funder types

Other

Identifiers

NCT05774574
11031 (Registry Identifier)

Details and patient eligibility

About

CBD may affect metabolic control and energy intake. However, there is currently little data regarding these specific outcomes in humans. Therefore, this study will investigate whether four weeks of supplementation with 60 mg/day CBD affects energy intake at a single meal, and or fasting blood-based markers of appetite regulation and metabolic health. Healthy, adult volunteers will be assigned to placebo or CBD supplementation, in a randomized controlled trial, comparing changes in outcomes across the supplementation period between groups.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Exclusion Criteria:

  • No history of any substance abuse
  • Have used tobacco regularly (>2x in a week) within the past 6 months
  • Are suffering from any condition that may affect study outcomes
  • Currently use any prescription or over-the-counter medications (except for hormonal contraception and simple painkillers)
  • Have given a standard blood donation within 30 days of screening
  • Are currently pregnant or lactating
  • Are allergic/intolerant to any ingredients in food items we provide during the study (relevant allergens: oats, milk)

Inclusion Criteria:

  • Males and females, aged 18-50, who do not meet the exclusion criteria

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

30 participants in 2 patient groups, including a placebo group

CBD
Experimental group
Description:
1 mL hemp oil containing 60 mg/mL CBD, daily.
Treatment:
Dietary Supplement: Cannabidiol (CBD) supplementation
Placebo
Placebo Comparator group
Description:
1 mL hemp oil containing 0 mg/mL CBD, daily.
Treatment:
Dietary Supplement: Placebo supplementation

Trial contacts and locations

1

Loading...

Central trial contact

Lewis J James, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems